Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness

被引:34
作者
Baba, Takashi [1 ,2 ]
Kawaguchi, Makiko [1 ]
Fukushima, Tsuyoshi [1 ]
Sato, Yuko [3 ]
Orikawa, Hiroshi [1 ,2 ]
Yorita, Kenji [1 ]
Tanaka, Hiroyuki [1 ]
Lin, Chen-Yong [4 ]
Sakoda, Sumio [2 ]
Kataoka, Hiroaki [1 ]
机构
[1] Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Kiyotake, Miyazaki 8891692, Japan
[2] Miyazaki Univ, Fac Med, Dept Oral & Maxillofacial Surg, Miyazaki, Japan
[3] Miyazaki Prefectural Ind Support Fdn, Miyazaki, Japan
[4] Univ Maryland, Greenebaum Canc Ctr, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
关键词
HAI-1; matriptase; oral squamous cell carcinoma; epithelial-to-mesenchymal transition; invasion; HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; TYPE-1; HAI-1; IN-VIVO; MATRIPTASE; EXPRESSION; INVASION; CANCER; HEAD; NECK;
D O I
10.1002/path.3993
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A loss of balance between cell membrane-associated proteases and their inhibitors may underlie cancer invasion and metastasis. We analysed the roles of a membrane- associated serine protease inhibitor, HAI-1, in oral squamous cell carcinoma (OSCC). While membranous HAI-1 was widely observed in cancer cells of human OSCC tissues, this was significantly reduced at the infiltrative invasion front. In vitro, HAI-1 was detected in all eight OSCC cell lines examined, in which its cognate membrane protease, matriptase was also expressed. HAI-1 expression knock-down (KD) in OSCC lines, SAS and HSC-3, reduced the growth of both lines in vitro but significantly enhanced SAS tumourigenicity in vivo, which was accompanied by histological changes suggestive of the epithelial-mesenchymal transition. Both HAI-1-KD lines also exhibited significantly enhanced migratory capability, and membrane-associated but not truncated HAI-1 was required to rescue this phenotype. Other OSCC lines (HSC-2, Sa3, Ca9-22) also showed enhanced migration in response to HAI-1 KD. The enhanced migration is partly attributed to dysregulation of matriptase, as simultaneous matriptase KD alleviated the migration of HAI-1-KD cells. HAI-1 deficiency also altered the expression of CD24, S100A4, CCND2 and DUSP6, all of which are involved in tumour progression. While matriptase was involved in the increased CD24 expression associated with HAI-1 deficiency, the protease appeared to be not responsible for the altered expression of other genes. Therefore, a matriptase-independent mechanism for the invasiveness associated with HAI-1 KD is also present. Together, these observations suggest that HAI-1 has a crucial suppressive role in OSCC cell invasiveness. Copyright (c) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 49 条
[1]   Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia [J].
Banerjee, AG ;
Bhattacharyya, I ;
Vishwanatha, JK .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) :865-875
[2]  
BRYNE M, 1995, VIRCHOWS ARCH, V427, P277
[3]   Type II Transmembrane Serine Proteases [J].
Bugge, Thomas H. ;
Antalis, Toni M. ;
Wu, Qingyu .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (35) :23177-23181
[4]   Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation [J].
Chen, Ya-Wen ;
Wang, Jehng-Kang ;
Chou, Feng-Pai ;
Chen, Chiu-Yuan ;
Rorke, Ellen A. ;
Chen, Li-Mei ;
Chai, Karl X. ;
Eckert, Richard L. ;
Johnson, Michael D. ;
Lin, Chen-Yong .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (41) :31755-31762
[5]   Hepatocyte Growth Factor Activator Inhibitor Type 1 Regulates Epithelial to Mesenchymal Transition through Membrane-Bound Serine Proteinases [J].
Cheng, Haixia ;
Fukushima, Tsuyoshi ;
Takahashi, Nobuyasu ;
Tanaka, Hiroyuki ;
Kataoka, Hiroaki .
CANCER RESEARCH, 2009, 69 (05) :1828-1835
[6]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[7]   Cancer invasion and metastasis: changing views [J].
Duffy, M. J. ;
McGowan, P. M. ;
Gallagher, W. M. .
JOURNAL OF PATHOLOGY, 2008, 214 (03) :283-293
[8]   Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin [J].
Fan, B ;
Wu, TD ;
Li, W ;
Kirchhofer, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (41) :34513-34520
[9]  
Fukai K, 2003, CANCER RES, V63, P8674
[10]   Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24 [J].
Fukushima, Tsuyoshi ;
Tezuka, Tomoaki ;
Shimomura, Takeshi ;
Nakano, Shinichi ;
Kataoka, Hiroaki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (25) :18634-18644